Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Unspecified Adult Solid Tumor - Protocol Specific”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00020371
What this trial is testing

BMS-247550 in Treating Patients With Cancers That Have Not Responded to Previous Therapy

Who this might be right for
Unspecified Adult Solid Tumor, Protocol SpecificNeutropenia
National Cancer Institute (NCI)
Early research (Phase 1)Study completedNCT00042809
What this trial is testing

Erlotinib, Trastuzumab, and Paclitaxel in Treating Patients With Advanced Solid Tumors

Who this might be right for
Unspecified Adult Solid Tumor, Protocol Specific
National Cancer Institute (NCI) 40
Testing effectiveness (Phase 2)UnknownNCT00004063
What this trial is testing

Cisplatin, Gemcitabine, Interferon Alfa, and Hyperthermia in Treating Patients With Advanced Cancer

Who this might be right for
Unspecified Adult Solid Tumor, Protocol Specific
The University of Texas Health Science Center, Houston 30
Not applicableStudy completedNCT00536601
What this trial is testing

High-Dose Chemotherapy With or Without Total-Body Irradiation Followed by Autologous Stem Cell Transplant in Treating Patients With Hematologic Cancer or Solid Tumors

Who this might be right for
Adult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in RemissionAdult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities+56 more
Roswell Park Cancer Institute 174
Early research (Phase 1)Ended earlyNCT00354185
What this trial is testing

PXD101 and 17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Metastatic or Unresectable Solid Tumors or Lymphoma

Who this might be right for
Adult Nasal Type Extranodal NK/T-cell LymphomaAnaplastic Large Cell LymphomaAngioimmunoblastic T-cell Lymphoma+57 more
National Cancer Institute (NCI) 36
Early research (Phase 1)Study completedNCT00004189
What this trial is testing

Rebeccamycin Analog and Cisplatin With or Without Filgrastim in Treating Patients With Advanced Cancer

Who this might be right for
LymphomaSmall Intestine CancerUnspecified Adult Solid Tumor, Protocol Specific
National Cancer Institute (NCI) 40
Early research (Phase 1)Study completedNCT00003706
What this trial is testing

LY231514 in Treating Patients With Locally Advanced or Metastatic Solid Tumors and Varying Degrees of Kidney Function

Who this might be right for
Unspecified Adult Solid Tumor, Protocol Specific
The University of Texas Health Science Center at San Antonio 50
Early research (Phase 1)Study completedNCT01191216
What this trial is testing

1-Methyl-D-Tryptophan and Docetaxel in Treating Patients With Metastatic Solid Tumors

Who this might be right for
Unspecified Adult Solid Tumor, Protocol Specific
National Cancer Institute (NCI) 27
Not applicableEnded earlyNCT00875004
What this trial is testing

Epoetin Beta in Patients Undergoing Chemotherapy for Solid Tumors

Who this might be right for
AnemiaUnspecified Adult Solid Tumor, Protocol Specific
Institut du Cancer de Montpellier - Val d'Aurelle 27
Large-scale testing (Phase 3)Study completedNCT00770172
What this trial is testing

G-CSF in Preventing Neutropenia in Patients With Solid Tumors Who Are Receiving Chemotherapy

Who this might be right for
Chemotherapeutic Agent ToxicityNeutropeniaUnspecified Adult Solid Tumor, Protocol Specific
Centre Francois Baclesse 140
Early research (Phase 1)Study completedNCT00049712
What this trial is testing

Monoclonal Antibody Therapy in Treating Patients With Refractory Advanced Solid Tumors or Lymphoma

Who this might be right for
LymphomaSmall Intestine CancerUnspecified Adult Solid Tumor, Protocol Specific
University of Wisconsin, Madison
Early research (Phase 1)Study completedNCT00006464
What this trial is testing

UCN-01 and Cisplatin in Treating Patients With Advanced or Metastatic Solid Tumors

Who this might be right for
Unspecified Adult Solid Tumor, Protocol Specific
City of Hope Medical Center
Not applicableStudy completedNCT00983359
What this trial is testing

Stereotactic Radiation Therapy in Treating Patients With Brain Metastases

Who this might be right for
Metastatic CancerUnspecified Adult Solid Tumor, Protocol Specific
Ohio State University Comprehensive Cancer Center 40
Testing effectiveness (Phase 2)Study completedNCT00607880
What this trial is testing

Study Comparing Two Types of Ports in Patients With Cancer Receiving Intravenous Chemotherapy

Who this might be right for
Unspecified Adult Solid Tumor, Protocol SpecificVascular Access Device Complications
Mayo Clinic 100
Not applicableStudy completedNCT00248547
What this trial is testing

Aprepitant in Preventing Nausea and Vomiting in Patients Who Are Undergoing a Stem Cell Transplant

Who this might be right for
Cancer
OHSU Knight Cancer Institute 40
Testing effectiveness (Phase 2)Study completedNCT00952848
What this trial is testing

Electrical Stimulation Therapy Using the MC5-A Scrambler in Reducing Peripheral Neuropathy Caused by Chemotherapy

Who this might be right for
Chemotherapeutic Agent ToxicityNeurotoxicityPain+2 more
Virginia Commonwealth University 18
Early research (Phase 1)Study completedNCT01096355
What this trial is testing

Gamma-Secretase Inhibitor RO4929097 in Treating Patients With Metastatic or Unresectable Solid Malignancies

Who this might be right for
Unspecified Adult Solid Tumor, Protocol Specific
National Cancer Institute (NCI) 28
Early research (Phase 1)Study completedNCT00103220
What this trial is testing

SJG-136 in Treating Patients With Advanced Solid Tumors

Who this might be right for
Unspecified Adult Solid Tumor, Protocol Specific
National Cancer Institute (NCI) 36
Not applicableStudy completedNCT01566279
What this trial is testing

Identify a Biomarker Predictive for Response on Everolimus in Solid Tumors (CPCT-03)

Who this might be right for
Unspecified Adult Solid Tumor, Protocol Specific
UMC Utrecht 73
Early research (Phase 1)Study completedNCT00078962
What this trial is testing

GTI-2040 and Gemcitabine in Treating Patients With Metastatic or Unresectable Solid Tumors

Who this might be right for
Unspecified Adult Solid Tumor, Protocol Specific
National Cancer Institute (NCI) 40
Next Page